Bluejay Diagnostics, Inc. (BJDX) vs Co-Diagnostics, Inc. (CODX)
- Bluejay Diagnostics, Inc. BJDX 2.35 +7.31%
- Co-Diagnostics, Inc. CODX 0.25 −7.41%
Bluejay Diagnostics, Inc. and Co-Diagnostics, Inc. are both Medical Devices companies. Bluejay Diagnostics, Inc. and Co-Diagnostics, Inc. are of similar size ($2.5M and $2.4M). Bluejay Diagnostics, Inc. has the higher net margin (0.00% vs −6,522.9%) and the higher return on invested capital (0.00% vs −337.7%). Across the 13 metrics below, Bluejay Diagnostics, Inc. leads on 10 and Co-Diagnostics, Inc. on 3.
Valuation
Profitability
| Metric | BJDX | CODX | Medical Devices median |
|---|---|---|---|
| Gross margin | 0.00% | 43.47% | 57.76% |
| Operating margin | 0.00% | (6,787.47%) | (14.84%) |
| Net margin | 0.00% | (6,522.91%) | (14.45%) |
| Free cash flow margin | 0.00% | (3,807.94%) | (5.70%) |
| Return on equity | (98.89%) | (174.77%) | (10.56%) |
| Return on assets | (81.07%) | (149.25%) | (17.26%) |
| Return on invested capital | 0.00% | (337.68%) | (5.22%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack